CYPRESS SEMICONDUCTOR CORPORATION | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
ON A GAAP BASIS | |||||||
(In thousands, except per-share data) | |||||||
(Unaudited) | |||||||
| |||||||
|
Three Months Ended | ||||||
|
April 2, 2017 |
|
January 1, 2017 | ||||
Revenues |
$ |
531,874 |
|
|
$ |
530,172 |
|
Costs and expenses: |
|
|
| ||||
Cost of revenues |
332,814 |
|
|
328,220 |
| ||
Research and development |
88,481 |
|
|
92,188 |
| ||
Selling, general and administrative |
76,114 |
|
|
76,839 |
| ||
Amortization of intangible assets |
48,249 |
|
|
52,104 |
| ||
Restructuring costs |
2,572 |
|
|
17,237 |
| ||
Impairment related to assets held for sale |
— |
|
|
1,960 |
| ||
Total costs and expenses |
548,230 |
|
|
568,548 |
| ||
Operating loss |
(16,356) |
|
|
(38,376) |
| ||
Interest and other expense, net |
(19,359) |
|
|
(24,389) |
| ||
Loss before income taxes and non-controlling interest |
(35,715) |
|
|
(62,765) |
| ||
Income tax provision |
(4,927) |
|
|
(790) |
| ||
Equity in net loss of equity method investees |
(5,076) |
|
|
(8,766) |
| ||
Net loss |
(45,718) |
|
|
(72,321) |
| ||
Net gain attributable to non-controlling interests |
(64) |
|
|
(46) |
| ||
Net loss attributable to Cypress |
$ |
(45,782) |
|
|
$ |
(72,367) |
|
Net loss per share attributable to Cypress: |
|
|
| ||||
Basic |
$ |
(0.14) |
|
|
$ |
(0.22) |
|
Diluted |
$ |
(0.14) |
|
|
$ |
(0.22) |
|
Cash dividend declared per share |
$ |
0.11 |
|
|
$ |
0.11 |
|
Shares used in net loss per share calculation: |
|
|
| ||||
Basic |
326,964 |
|
|
322,800 |
| ||
Diluted |
326,964 |
|
|
322,800 |
|